Pacer Advisors’s Clorox CLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.06M | Sell |
10,189
-8,293
| -45% | -$940K | ﹤0.01% | 1191 |
|
|
2025
Q4 | $1.86M | Buy |
18,482
+7,248
| +65% | +$787K | ﹤0.01% | 1141 |
|
|
2025
Q3 | $1.39M | Sell |
11,234
-10,463
| -48% | -$1.3M | ﹤0.01% | 1264 |
|
|
2025
Q2 | $2.61M | Buy |
21,697
+15,412
| +245% | +$2.06M | 0.01% | 913 |
|
|
2025
Q1 | $925K | Sell |
6,285
-3,897
| -38% | -$595K | ﹤0.01% | 1236 |
|
|
2024
Q4 | $1.65M | Sell |
10,182
-3,990
| -28% | -$653K | ﹤0.01% | 1104 |
|
|
2024
Q3 | $2.31M | Sell |
14,172
-540
| -4% | -$80K | ﹤0.01% | 906 |
|
|
2024
Q2 | $2.01M | Buy |
14,712
+6,177
| +72% | +$858K | ﹤0.01% | 923 |
|
|
2024
Q1 | $1.31M | Sell |
8,535
-1,621
| -16% | -$242K | ﹤0.01% | 1082 |
|
|
2023
Q4 | $1.45M | Sell |
10,156
-4,353
| -30% | -$580K | ﹤0.01% | 932 |
|
|
2023
Q3 | $1.9M | Sell |
14,509
-510
| -3% | -$77.5K | 0.01% | 622 |
|
|
2023
Q2 | $2.39M | Buy |
15,019
+5,823
| +63% | +$939K | 0.01% | 684 |
|
|
2023
Q1 | $1.46M | Buy |
9,196
+8,423
| +1,090% | +$1.26M | 0.01% | 789 |
|
|
2022
Q4 | $108K | Sell |
773
-9,778
| -93% | -$1.39M | ﹤0.01% | 2578 |
|
|
2022
Q3 | $1.35M | Buy |
10,551
+1,539
| +17% | +$222K | 0.01% | 474 |
|
|
2022
Q2 | $1.27M | Buy |
9,012
+2,390
| +36% | +$341K | 0.01% | 503 |
|
|
2022
Q1 | $921K | Sell |
6,622
-1,712
| -21% | -$262K | 0.01% | 986 |
|
|
2021
Q4 | $1.45M | Sell |
8,334
-7,021
| -46% | -$1.17M | 0.01% | 989 |
|
|
2021
Q3 | $2.54M | Buy |
15,355
+1,177
| +8% | +$203K | 0.03% | 620 |
|
|
2021
Q2 | $2.55M | Buy |
14,178
+6,987
| +97% | +$1.28M | 0.04% | 544 |
|
|
2021
Q1 | $1.39M | Sell |
7,191
-759
| -10% | -$146K | 0.02% | 639 |
|
|
2020
Q4 | $1.6M | Sell |
7,950
-4,992
| -39% | -$1.03M | 0.03% | 510 |
|
|
2020
Q3 | $2.72M | Sell |
12,942
-2,108
| -14% | -$469K | 0.06% | 301 |
|
|
2020
Q2 | $3.3M | Buy |
+15,050
| New | +$3.01M | 0.07% | 219 |
|
|
2020
Q1 | – | Sell |
-14,146
| Closed | -$2.17M | – | 748 |
|
|
2019
Q4 | $2.17M | Sell |
14,146
-2,868
| -17% | -$429K | 0.1% | 242 |
|
|
2019
Q3 | $2.58M | Buy |
17,014
+2,726
| +19% | +$431K | 0.06% | 380 |
|
|
2019
Q2 | $2.19M | Buy |
14,288
+2,034
| +17% | +$311K | 0.05% | 434 |
|
|
2019
Q1 | $1.97M | Buy |
+12,254
| New | +$1.9M | 0.05% | 300 |
|
|
2018
Q4 | – | Sell |
-7,037
| Closed | -$1.06M | – | 636 |
|
|
2018
Q3 | $1.06M | Buy |
7,037
+1,108
| +19% | +$157K | 0.04% | 632 |
|
|
2018
Q2 | $802K | Buy |
5,929
+992
| +20% | +$122K | 0.04% | 737 |
|
|
2018
Q1 | $657K | Buy |
4,937
+792
| +19% | +$106K | 0.04% | 645 |
|
|
2017
Q4 | $617K | Buy |
4,145
+1,230
| +42% | +$167K | 0.04% | 629 |
|
|
2017
Q3 | $385K | Buy |
2,915
+273
| +10% | +$36.7K | 0.03% | 787 |
|
|
2017
Q2 | $352K | Buy |
2,642
+203
| +8% | +$27.4K | 0.03% | 785 |
|
|
2017
Q1 | $329K | Buy |
2,439
+77
| +3% | +$9.97K | 0.04% | 722 |
|
|
2016
Q4 | $283K | Sell |
2,362
-14
| -0.6% | -$1.65K | 0.04% | 716 |
|
|
2016
Q3 | $297K | Sell |
2,376
-14
| -0.6% | -$1.83K | 0.05% | 615 |
|
|
2016
Q2 | $331K | Buy |
2,390
+246
| +11% | +$31.9K | 0.05% | 526 |
|
|
2016
Q1 | $270K | Buy |
2,144
+108
| +5% | +$13.7K | 0.06% | 320 |
|
|
2015
Q4 | $258K | Buy |
+2,036
| New | +$253K | 0.06% | 324 |
|
Other funds holding CLX
VCM
VPM
DAM
Pacer Advisors's CLX Position: Q1 2026 in Review
Pacer Advisors reduced its Clorox (CLX) stake by 45% in Q1 2026, selling an estimated $940K and leaving 10,189 shares worth $1.06M. The position accounts for ﹤0.01% of the portfolio, ranked #1191.
Pacer Advisors first reported a position in CLX in Q4 2015 and has held it in 40 quarters since. The position peaked at $3.3M in Q2 2020. 1,080 funds tracked by Wall St. Rank hold CLX as of Q1 2026.
- Pacer Advisors held 10,189 shares of Clorox worth $1.06M as of Q1 2026.
- Pacer Advisors sold 8,293 Clorox shares in Q1 2026, an estimated $940K.
- Clorox made up ﹤0.01% of Pacer Advisors's portfolio in Q1 2026, its #1191 holding.
- Pacer Advisors first reported a position in Clorox in Q4 2015 and has held it in 40 quarters since.
- Pacer Advisors's Clorox position peaked at $3.3M in Q2 2020.
- 1,080 funds tracked by Wall St. Rank held Clorox as of Q1 2026.
Based on Pacer Advisors's 13F filing for Q1 2026, filed 6 May 2026.